Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Clinical trial NCT06947967 · RECRUITING

Trial details

NCT number: NCT06947967
Sponsor: Chipscreen Biosciences, Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2025-08-12
Primary completion: 2032-12-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.